Adequate 0 8 0 8 O
organ 9 14 9 14 O
function 15 23 15 23 O
as 24 26 24 26 O
outlined 27 35 27 35 O
below 36 41 36 41 O
( 42 43 42 43 O
unless 43 49 43 49 O
due 50 53 50 53 O
to 54 56 54 56 O
leukemia 57 65 57 65 B-cancer
) 65 66 65 66 O

Alanine 0 7 67 74 B-clinical_variable
aminotransferase 8 24 75 91 I-clinical_variable
( 25 26 92 93 I-clinical_variable
ALT 26 29 93 96 I-clinical_variable
) 29 30 96 97 I-clinical_variable
( 31 32 98 99 O
serum 32 37 99 104 B-clinical_variable
glutamate 38 47 105 114 I-clinical_variable
pyruvate 48 56 115 123 I-clinical_variable
transaminase 57 69 124 136 I-clinical_variable
[ 70 71 137 138 I-clinical_variable
SGPT 71 75 138 142 I-clinical_variable
] 75 76 142 143 I-clinical_variable
) 76 77 143 144 O
and/or 78 84 145 151 O
aspartate 85 94 152 161 B-clinical_variable
aminotransferase 95 111 162 178 I-clinical_variable
( 112 113 179 180 I-clinical_variable
AST 113 116 180 183 I-clinical_variable
) 116 117 183 184 I-clinical_variable
( 118 119 185 186 O
serum 119 124 186 191 B-clinical_variable
glutamic 125 133 192 200 I-clinical_variable
oxaloacetic 134 145 201 212 I-clinical_variable
transaminase 146 158 213 225 I-clinical_variable
[ 159 160 226 227 I-clinical_variable
SGOT 160 164 227 231 I-clinical_variable
] 164 165 231 232 I-clinical_variable
) 165 166 232 233 O
= 167 168 234 235 O
< 168 169 235 236 O
3 170 171 237 238 B-upper_bound
x 172 173 239 240 I-upper_bound
upper 174 179 241 246 I-upper_bound
limit 180 185 247 252 I-upper_bound
of 186 188 253 255 I-upper_bound
normal 189 195 256 262 I-upper_bound
( 196 197 263 264 I-upper_bound
ULN 197 200 264 267 I-upper_bound
) 200 201 267 268 I-upper_bound
or 202 204 269 271 O
= 205 206 272 273 O
< 206 207 273 274 O
5 208 209 275 276 B-upper_bound
x 210 211 277 278 I-upper_bound
ULN 212 215 279 282 I-upper_bound
if 216 218 283 285 O
related 219 226 286 293 O
to 227 229 294 296 O
disease 230 237 297 304 O

Breast 0 6 305 311 O
feeding 7 14 312 319 O
females 15 22 320 327 B-gender

Cardiac 0 7 328 335 B-clinical_variable
ejection 8 16 336 344 I-clinical_variable
fraction 17 25 345 353 I-clinical_variable
> 26 27 354 355 O
= 27 28 355 356 O
40 29 31 357 359 B-lower_bound
% 31 32 359 360 I-lower_bound
( 33 34 361 362 O
by 34 36 362 364 O
either 37 43 365 371 O
cardiac 44 51 372 379 B-treatment
echocardiogram 52 66 380 394 I-treatment
[ 67 68 395 396 I-treatment
echo 68 72 396 400 I-treatment
] 72 73 400 401 I-treatment
or 74 76 402 404 O
multi 77 82 405 410 B-treatment
gated 83 88 411 416 I-treatment
acquisition 89 100 417 428 I-treatment
[ 101 102 429 430 I-treatment
MUGA 102 106 430 434 I-treatment
] 106 107 434 435 I-treatment
scan 108 112 436 440 I-treatment
) 112 113 440 441 O

Newly 0 5 442 447 O
diagnosed 6 15 448 457 O
or 16 18 458 460 O
relapsed 19 27 461 469 O
mixed 28 33 470 475 B-cancer
phenotype 34 43 476 485 I-cancer
acute 44 49 486 491 I-cancer
leukemia 50 58 492 500 I-cancer
( 59 60 501 502 I-cancer
MPAL 60 64 502 506 I-cancer
) 64 65 506 507 I-cancer

Patients 0 8 508 516 O
with 9 13 517 521 O
active 14 20 522 528 B-cancer
secondary 21 30 529 538 I-cancer
malignancy 31 41 539 549 I-cancer
will 42 46 550 554 O
not 47 50 555 558 O
be 51 53 559 561 O
eligible 54 62 562 570 O
unless 63 69 571 577 O
approved 70 78 578 586 O
by 79 81 587 589 O
the 82 85 590 593 O
principal 86 95 594 603 O
investigator 96 108 604 616 O

Patients 0 8 617 625 O
with 9 13 626 630 O
active 14 20 631 637 O
, 20 21 637 638 O
uncontrolled 22 34 639 651 B-chronic_disease
infections 35 45 652 662 I-chronic_disease

Serum 0 5 663 668 B-clinical_variable
creatinine 6 16 669 679 I-clinical_variable
= 17 18 680 681 O
< 18 19 681 682 O
3 20 21 683 684 B-upper_bound
mg 22 24 685 687 I-upper_bound
/ 24 25 687 688 I-upper_bound
dL 25 27 688 690 I-upper_bound

Total 0 5 691 696 B-clinical_variable
bilirubin 6 15 697 706 I-clinical_variable
= 16 17 707 708 O
< 17 18 708 709 O
2.5 19 22 710 713 B-upper_bound
mg 23 25 714 716 I-upper_bound
/ 25 26 716 717 I-upper_bound
dL 26 28 717 719 I-upper_bound

Women 0 5 720 725 B-gender
of 6 8 726 728 O
childbearing 9 21 729 741 O
potential 22 31 742 751 O
must 32 36 752 756 O
have 37 41 757 761 O
a 42 43 762 763 O
negative 44 52 764 772 B-pregnancy
serum 53 58 773 778 I-pregnancy
or 59 61 779 781 I-pregnancy
urine 62 67 782 787 I-pregnancy
pregnancy 68 77 788 797 I-pregnancy
test 78 82 798 802 O
within 83 89 803 809 O
7 90 91 810 811 B-upper_bound
days 92 96 812 816 I-upper_bound

bone 0 4 817 821 O
marrow 5 11 822 828 O
result 12 18 829 835 O
interpreted 19 30 836 847 O
by 31 33 848 850 O
the 34 37 851 854 O
reading 38 45 855 862 O
pathologist 46 57 863 874 O
( 58 59 875 876 O
or 59 61 876 878 O
tissue 62 68 879 885 B-treatment
biopsy 69 75 886 892 I-treatment
for 76 79 893 896 O
cases 80 85 897 902 O
of 86 88 903 905 O
extramedullary 89 103 906 920 B-chronic_disease
disease 104 111 921 928 I-chronic_disease
) 111 112 928 929 O

documentation 0 13 930 943 O
of 14 16 944 946 O
recent 17 23 947 953 O
(= 24 26 954 956 O
< 26 27 956 957 O
6 28 29 958 959 B-upper_bound
months 30 36 960 966 I-upper_bound
from 37 41 967 971 O
screening 42 51 972 981 O
) 51 52 981 982 O
outside 53 60 983 990 O
reports 61 68 991 998 O
is 69 71 999 1001 O
acceptable 72 82 1002 1012 O

women 0 5 1013 1018 B-gender
of 6 8 1019 1021 O
childbearing 9 21 1022 1034 O
potential 22 31 1035 1044 O
and 32 35 1045 1048 O
men 36 39 1049 1052 O
must 40 44 1053 1057 O
agree 45 50 1058 1063 B-contraception_consent
to 51 53 1064 1066 I-contraception_consent
use 54 57 1067 1070 I-contraception_consent
contraception 58 71 1071 1084 I-contraception_consent
at 72 74 1085 1087 O
study 75 80 1088 1093 O
entry 81 86 1094 1099 O
and 87 90 1100 1103 O
for 91 94 1104 1107 O
the 95 98 1108 1111 O
duration 99 107 1112 1120 O
of 108 110 1121 1123 O
active 111 117 1124 1130 O
study 118 123 1131 1136 O
treatment 124 133 1137 1146 O

